Cosalane
Alternative Names: NSC 640067; NSC 658586Latest Information Update: 12 Mar 2008
At a glance
- Originator National Cancer Institute (USA); Purdue University; University of Missouri-Kansas City
- Developer National Cancer Institute (USA); University of Missouri-Kansas City
- Class Antiretrovirals; Cholestanes
- Mechanism of Action HIV envelope protein gp120 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued HIV infections